BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.670
-0.090 (-5.11%)
At close: Feb 27, 2026, 4:00 PM EST
1.650
-0.020 (-1.20%)
After-hours: Feb 27, 2026, 7:40 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceuticals
2.27M1.38M375.00K--
Pharmaceuticals Growth
64.20%268.00%---
Total
2.27M1.38M375.00K--
Total Growth
64.20%268.00%---

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
2.27M1.38M375.00K--
United States Growth
64.20%268.00%---
Total
2.27M1.38M375.00K--
Total Growth
64.20%268.00%---
Source: S&P Global Market Intelligence.